Prolongation of Cardiac Allograft Survival Using Dendritic Cells Treated with NF-κB Decoy Oligodeoxyribonucleotides
Open Access
- 1 May 2000
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 1 (5) , 430-437
- https://doi.org/10.1006/mthe.2000.0060
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- CYCLOSPORINE A INHIBITS THE EXPRESSION OF COSTIMULATORY MOLECULES ON IN VITRO-GENERATED DENDRITIC CELLSTransplantation, 1999
- PHENOTYPE, FUNCTION, AND IN VIVO MIGRATION AND SURVIVAL OF ALLOGENEIC DENDRITIC CELL PROGENITORS GENETICALLY ENGINEERED TO EXPRESS TGF-??1,2Transplantation, 1998
- Dendritic Cell Survival and Maturation Are Regulated by Different Signaling PathwaysThe Journal of Experimental Medicine, 1998
- PROTECTION AGAINST ALLOGRAFT REJECTION WITH INTERCELLULAR ADHESION MOLECULE-1 ANTISENSE OLIGODEOXYNUCLEOTIDES1Transplantation, 1998
- Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1995
- Expression of relB is required for the development of thymic medulla and dendritic cellsNature, 1995
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1992
- An L-arginine-dependent mechanism mediates kupffer cell inhibition of hepatocyte protein synthesis in vitroThe Journal of Experimental Medicine, 1989
- Effects of Cyclosporine A on T Cell Development and Clonal DeletionScience, 1988